Lv2
140 积分 2025-11-06 加入
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
1个月前
已完结
Precision dosing of systemic antifungals in adults: therapeutic drug monitoring, empiric dose optimization and barriers to implementation
4个月前
已完结
Systemic influence of immunosuppressive drugs on small and large bowel transport and barrier function
4个月前
已关闭
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
4个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
4个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
5个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
5个月前
已完结
Torsade de Pointes and QT Prolongation Among Antifungal Triazoles: A Real-World, Retrospective, Observational, Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
6个月前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
6个月前
已完结
Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
6个月前
已完结
皖公网安备34019202002308
